Srinivasan N, Olivier T, Haslam A, Prasad V, et al. Imatinib remains the best frontline therapy in patients with chronic myeloid leukemia: Critical analysis of the ASC4FIRST trial. Am J Hematol 2024 Sep 28. doi: 10.1002/ajh.27477.
PMID: 39340218